Ellen O’Meara, PhD

OMeara_Ellen__205x293.jpg

“Our work in the Breast Cancer Surveillance Consortium is to make notable contributions to understanding cancer risk, screening effectiveness, and how to ensure the best outcomes for women with breast cancer.”

Ellen O’Meara, PhD

Principal Collaborative Scientist, Kaiser Permanente Washington Health Research Institute

Biography

Ellen O’Meara, PhD, came to Kaiser Permanente Washington Health Research Institute in 2009 with an array of scientific interests. The common thread across her more than two decades of research experience is studying the epidemiology of common diseases in adults, such as cancer, Alzheimer's, and cardiovascular disease.

Due to her strong interests in screening for disease and outcomes after diagnosis, Dr. O’Meara co-directs the Kaiser Permanente Washington-led Statistical Coordinating Center for the Breast Cancer Surveillance Consortium—a national network of breast imaging and breast cancer researchers. One of her goals is to find ways to optimize breast cancer screening—that is, to find the best balance of benefits and harms in subgroups of women based on their risks.

Dr. O’Meara’s other professional activities include memberships in the Society for Epidemiologic Research and the American Society of Preventive Oncology.

Research interests and experience

Recent publications

Mukamal KJ, Pai JK, O'Meara ES, Tracy RP, Psaty BM, Kuller LH, Newman AB, Yende S, Curhan GC, Siscovick DS, Rimm EB. CRP gene variation and risk of community-acquired pneumonia.  Respirology. 2010 Jan;15(1):160-4. Epub 2009 Nov 23. PubMed

 

News

Breast_Cancer_Risk_Prediction_Model_1col.jpg

Predicting breast cancer risk after a high-risk benign lesion diagnosis

New study will develop risk models to improve clinical guidelines and practice.

Research

Cancer-prevention-story_1col.jpg

Improving cancer prevention and early detection

How KPWHRI is contributing to better cancer screening and better outcomes for patients.

Research

illustration nurse and patient mammogram

Roundup of 3 recent studies on breast cancer screening

New research spotlights overdiagnosis, MRI before surgery, and a new way of predicting breast cancer risk